NFE2L2 and non-small cell lung carcinoma: NSCLC can exhibit dysregulated KEAP1–NRF2 signaling, which drives xCT activation [100], and [18F]FSPG PET enables noninvasive readouts of NRF2-linked system Xc− activity [112].